Scalable AI Tools

Cansera’s platform is built with scalability, speed, and reliability in mind. We employ modern cloud computing infrastructure and software engineering best practices to ensure that our AI tools can handle massive datasets and be readily accessible to users around the world. Our technology is deployed as a cloud-native, modular system that can expand with growing demand.

Cloud-Native and Containerized Platform

To make our solution both powerful and convenient, we’ve developed CellLogic as a cloud-hosted Software-as-a-Service. Users will be able to upload data and run analyses via a secure web platform, without needing specialized hardware on site. Under the hood, the heavy lifting is done in the cloud with high-performance computing instances. We utilize containerization (e.g. Docker/Singularity containers) to encapsulate our algorithms and their dependencies, meaning our software runs in a consistent environment. Each component of the pipeline – from image tiling to cell classification – is packaged in its own container, orchestrated by standard cloud tools. This approach offers several benefits:

• Easy Deployment: Containers allow one-click deployment of the entire pipeline on virtually any infrastructure. We have automated continuous integration (CI/CD) pipelines to test and deploy new versions of the software seamlessly. Updates and improvements roll out to all users without manual installs.
• Consistency: Because the execution environment is standardized, results are reproducible across different machines and sites. A lab in Los Angeles and a lab in London will get the same results given the same data – eliminating the “it works on my computer” problem.
• Security & Compliance: Our cloud architecture is set up within virtual private cloud networks, with data encryption and access controls to protect sensitive information. The use of containers also simplifies compliance with regulatory requirements (like isolating patient data processing), keeping the system in line with healthcare data standards (HIPAA, GDPR).
• Portability: While we expect most users to prefer our managed cloud service, the containerized design means the platform can also be deployed on-premises if needed (e.g., in a hospital’s own servers for clinical use).

High-Throughput, Parallel Processing

Scalability isn’t just a buzzword for us – it’s a concrete engineering target. We recognize that imaging an entire blood sample yields huge data (millions of cells per slide, multiple slides per study), so our pipeline is optimized for speed at scale. Leveraging cloud-native resources, we implement batch processing and parallel computation at every step. For example, the tiling of images and the evaluation of tiles by the RED algorithm are distributed across many CPU/GPU nodes concurrently. In practice, this means we can analyze a full whole-slide image in mere minutes rather than hours. What does this performance translate to for users? It means that even high-throughput projects – say a clinical trial analyzing hundreds of patient samples, or a drug company screening dozens of conditions – can be handled in a timely manner. A batch of slides can be queued and processed overnight (or faster), with results ready by the next morning, rather than backlogging a lab for weeks. This high-throughput capability is crucial for our mission of broad impact: it ensures that as our user base grows and data volumes explode, the platform can keep up without compromising performance.

Modular and Future-Proof Architecture

Another key aspect of our platform is its modularity. We have structured CellLogic as a series of distinct modules or microservices, each with well-defined inputs and outputs. For example, there is a module for image tiling, another for running the RED autoencoder, another for cell segmentation (BLUE), another for feature extraction, and so on. This modular design makes the system extensible and future-proof. As new algorithms or improvements emerge, we can upgrade one component without disrupting the others. If a radically better segmentation algorithm comes along, we can slot it into the BLUE stage; if new anomaly detection techniques arise, we can incorporate them into RED’s module. The pipeline’s inputs/outputs are standardized, so modules can be swapped or updated as long as they adhere to these interfaces. This approach insulates the platform against technological obsolescence – it’s designed to evolve over time. For users, a modular setup also means flexibility. Advanced users or partners could plug in their own analysis module at certain points, or request custom analytics on the rare cells . Our vision includes providing an API and integration hooks so that the platform can connect with laboratory information systems and other tools in a research or clinical lab’s workflow.

Crucially, we emphasize reproducibility and validation at each step of expansion. All code is version-controlled and every analysis can be traced to the exact algorithm version and parameters used. Moreover, we embrace open science principles: once matured, the core software (containers and trained models) will be released in open-source form, inviting the community to contribute and verify its performance. This transparent approach builds trust in the tool and accelerates innovation (as other researchers can build new modules or analyses around our platform). By combining modern cloud engineering with open, modular design, Cansera’s CellLogic is scalable, robust, and ready to grow. As new data pours in and new challenges arise, our architecture can adapt – adding capacity, incorporating new techniques, and continuously improving. This ensures that our AI tools remain at the cutting edge of rare-cell analysis and can reliably serve the needs of both research and, eventually, clinical users on a global scale.